Axent Holdings Pty Ltd t/a Axent Global v Compusign Australia Pty Ltd
Case
•
[2020] FCA 1373
•25 September 2020
Details
AGLC
Case
Decision Date
Axent Holdings Pty Ltd t/a Axent Global v Compusign Australia Pty Ltd [2020] FCA 1373
[2020] FCA 1373
25 September 2020
CaseChat Overview and Summary
Axent Holdings Pty Ltd, trading as Axent Global, brought an action against Compusign Australia Pty Ltd in the Federal Court of Australia, seeking a declaration that certain products manufactured by Compusign infringe a patent held by Axent. The patent, which is Australian Patent No. 2005308453, relates to a changing sign system for use as a variable speed limit sign on roadways. The dispute centred on whether Compusign's products infringed the patent and whether the patent was valid and enforceable. The case also involved issues around the patent's interpretation, specifically whether the claims were method or product claims, and if they contained limitations by result. Additionally, the court had to consider several defences raised by Compusign, including the defence of Crown use, innocent infringement, prior use, and the patent's alleged invalidity on various grounds.
The court found that the patent claims were product claims and that they contained a limitation by result. It held that Compusign's products did not infringe the patent because they did not meet the specific limitations set out in the patent claims. The court also determined that the patent was wholly invalid due to a lack of inventive step and partially invalid for want of novelty. The court found that the patent did not meet the criteria for novelty and inventive step as required by the Patents Act. Furthermore, the court rejected Compusign's defences of Crown use, innocent infringement, and prior use, finding that these defences did not apply to the circumstances of the case.
The Federal Court of Australia held that the patent held by Axent was invalid and that Compusign did not infringe the patent. Consequently, the court dismissed Axent's claim in its entirety. The court ordered that the respondents/cross-claimants file and serve a proposed minute of orders and written submissions on costs by a specified date, to which the applicant/cross-respondent would respond. The court also provided a timeline for any reply submissions and noted that issues relating to the form of final orders or costs would be determined on the papers, without an oral hearing.
The court found that the patent claims were product claims and that they contained a limitation by result. It held that Compusign's products did not infringe the patent because they did not meet the specific limitations set out in the patent claims. The court also determined that the patent was wholly invalid due to a lack of inventive step and partially invalid for want of novelty. The court found that the patent did not meet the criteria for novelty and inventive step as required by the Patents Act. Furthermore, the court rejected Compusign's defences of Crown use, innocent infringement, and prior use, finding that these defences did not apply to the circumstances of the case.
The Federal Court of Australia held that the patent held by Axent was invalid and that Compusign did not infringe the patent. Consequently, the court dismissed Axent's claim in its entirety. The court ordered that the respondents/cross-claimants file and serve a proposed minute of orders and written submissions on costs by a specified date, to which the applicant/cross-respondent would respond. The court also provided a timeline for any reply submissions and noted that issues relating to the form of final orders or costs would be determined on the papers, without an oral hearing.
Details
Key Legal Topics
Areas of Law
-
Intellectual Property Law
Legal Concepts
-
Patent Infringement
-
Patent Validity
-
Novelty
-
Inventive Step
-
Claim Construction
Actions
Download as PDF
Download as Word Document
Most Recent Citation
Sun Pharma ANZ Pty Ltd v Otsuka Pharmaceutical Co Ltd [2025] FCA 44
Cases Cited
108
Statutory Material Cited
16
Apotex Pty Ltd v Warner-Lambert Company LLC (No 2)
[2016] FCA 1238
Roads Corporation v Axent Holdings Pty Ltd
[2011] APO 43
Australian Securities and Investments Commission v Rich
[2005] NSWSC 417